InSightec: Prostatic Neoplasms trials

The registry lists 10 Prostatic Neoplasms studies with InSightec as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 1 2Phase 2 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate LesionsCompletedNCT01657942Not applicableResults posted
• ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of PainTerminatedNCT00981578Not applicableResults posted
• ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of PainCompletedNCT00656305Not applicableResults posted
• Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate LesionsActive, not recruitingNCT03998657Not applicable
• Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate CancerTerminatedNCT02968784Not applicable
• Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Intermediate Risk Prostate Cancer: Feasibility StudyCompletedNCT01226576Not applicable
• Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple MyelomaCompletedNCT01091883Not applicable
• Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone SystemCompletedNCT01085565Phase 2
• Safety Evaluation of ExAblate MRgFUS for Prostate CancerCompletedNCT00811265Phase 1
• MR Guided Focused Ultrasound Surgery of Metastatic Bone TumorsCompletedNCT00350233Phase 1